REFERENCES
- Alberts D. S., Chang S. Y., Chen H. S., et al. 13 comparative pharmacokinetics of chlorambucil and melphalan in man; recent results in cancer research. Fortschritte der Krebsforschung 1980; 74: 124–131, [INFOTRIEVE]
- Annunziata R., Benaglia M., Cinquini M., Cozzi F. Poly(ethylene glycol)-supported aniline—a useful starting material for the soluble polymer-supported synthesis of imines and 1,2,3,4-tetrahydroquinolines. Eur. J. Org. Chem. 2002, 7: 1184–1190, [CSA], [CROSSREF]
- Baker-Woudenberg I. A., ten Kate M. T., Guo L., et al. Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection. Antimicrob. Agents Chemother. 2002; 46(8)2575–2581, [CSA], [CROSSREF]
- Bielawska A., Bielawski K., Muszynska A. Synthesis and biological evaluation of new cyclic amidine analogs of chlorambucil. IL Farmaco. 2004; 59: 111–117, [INFOTRIEVE], [CSA], [CROSSREF]
- Caliceti P., Salmaso S., Semenzato A., et al. Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery. Bioconjug. Chem. 2003; 14(5)899–908, [INFOTRIEVE], [CSA], [CROSSREF]
- Chen S., Huang Z., Huang J. Synthesis and characterization of novel kinds of polyethylene oxide drugs containing 5-fluorouracil and nitrogen mustard at one end and 4-amino-N-(2-pyrimidinyl) benzene sulfonamide at the other end. Eur. Polym. J. 2000; 36: 1703–1710, [CSA], [CROSSREF]
- Coggiola B., Pagliai F., Allegrone G., et al. Synthesis and biological activity of mustard derivatives of combretastatins. Bioorg. Med. Chem. Lett. 2005; 15: 3551–3554, [INFOTRIEVE], [CSA], [CROSSREF]
- Dhoot N., Wheatley M. Microencapsulatedliposomes incontrolled drug delivery: strategies to modulate drug release and eliminate the bhurst effect. J. Pharm. Sci. 2003; 92(3)679–689, [INFOTRIEVE], [CSA], [CROSSREF]
- Dimitrakopoulos P. Longitudinal relaxation of initially straight flexible and stiff polymers. Phys. Rev. Lett. 2004; 93(21)217801(1)–217801(4), [CSA], [CROSSREF]
- Farmer P. B. Metabolism and reactions of alkylating agents. Pharmacol. Therap. 1987; 35: 301–358, [CSA], [CROSSREF]
- Giyoong T., Kornfield J. A., Hubbell J. A., et al. Ordering transitions of fluoroalkyl-ended poly(ethylene glycol): rheology and SANS. Macromolecules 2002; 35: 4448–4457, [CSA], [CROSSREF]
- Giyoong T., Kornfield J. A., Hubbell J. A., et al. Hydrogels with controlled, surface erosion characteristics self-assembly of fluoroalkyl-ended poly(ethylene glycol). Macromolecules. 2001; 34: 6409–6419, [CSA], [CROSSREF]
- Hennink W. E., van Nostrum C. F. Novel crosslinking methods to design hydrogels. Adv. Drug. Deliv. Rev. 2002; 54: 13–36, [INFOTRIEVE], [CSA], [CROSSREF]
- Haque T., Chen H., Ouyang W., et al. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules. Mol. Pharm. 2005; 2(1)29–36, [INFOTRIEVE], [CSA], [CROSSREF]
- Jia Z., Zhang H., Huang J. Synthesis of polyethylene glycol with sulfadiazine and chlorambucil end groups and investigation of its antitumor activity. Bioorg. Med. Chem. Lett. 2003; 13: 2531–2534, [INFOTRIEVE], [CSA], [CROSSREF]
- Konovalova N. P., D'yachkovskaya R. F., Volkova L. M., Varfolomeev V. N. The nitroxyl radical Tempol as a modulator of 6-mercaptopurine toxicity and antitumor activity. Voprosy Onkologii. 1996; 42(3)57–63, [INFOTRIEVE], [CSA]
- Kwon T., Chao D. L., Malloy K., et al. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of ransient focal ischemia. J. Neurotraum. 2004; 21(10)1405–1414, [CSA], [CROSSREF]
- McConnell H. M. Molecular motion in biological membranes. Spinlabeling. Theory and applications. Academic Press, New York 1976
- McLean A., Newell D., Baker G., Connors T. The metabolism of chlorambucil. Biochem. Pharmacol. 1980; 29: 2039–2047, [INFOTRIEVE], [CSA], [CROSSREF]
- Mehlhorn R. J., Packer L. Bioenergetic studies of cells with spin probes. Ann. N. Y. Acad. Sci. 1983; 414: 180–189, [INFOTRIEVE], [CSA]
- Monti E., Supino R., Colleoni M., et al. Nitroxide tempol impairs mitochondrail function and induces apoptosis in HL60 cells. J. Cell. Biochem. 2001; 82: 271–276, [INFOTRIEVE], [CSA], [CROSSREF]
- Panasci L., Paiement J. P., Christodoulopoulos G., et al. Chlorambucil drug resistence in CLL. The emerging role of DNA repair. Clin. Cancer Res. 2001; 7: 454–461, [INFOTRIEVE], [CSA]
- Parker L. L., Anderson F. M., O'Hare C. C., et al. Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. Biorgan. Med. Chem. 2005; 13: 2389–2395, [CSA], [CROSSREF]
- Pietschmann C. Antibodies as selective weapons. Livingbridges 2001; 1: 54–57, [CSA]
- Prabhutendolkar A., Mathias E., Liu L., et al (2005) Study of the delivery of the hydrophobic drugs by fluoroalkyl terminated polyethylene glycol hydrogels using NMR and ESR spectroscopy. 229th ACS National Meeting, San Diego, CA, March, 13–172005
- Proctor S. J., White J., Jones G. L. An international approach to the treatment of Hodgkin's disease in the elderly: launch of Shield study progamme. Eur. J. Haematol. Suppl. 2005; 66: 63–67, [INFOTRIEVE], [CSA]
- Ravizza R., Cereda E., Monti E., Gariboldi M. The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cells. Int. J. Oncol. 2004; 25: 1817–1822, [INFOTRIEVE], [CSA]
- Vold R. L., Waugh J. S., Klein M. P., Phelps D. E. Measurement of spin relaxation in complex systems. J. Chem. Phy. 1968; 48: 3831–3832, [CSA], [CROSSREF]
- Xu B., Li L., Yekta A., et al. Synthesis, characterization, and rheological behavior of polyethylene glycols end-capped with fluorocarbon hydrophobes. Langmuir. 1997; 13: 2447–2456, [CSA], [CROSSREF]